Home Cart 0 Sign in  

[ CAS No. 19171-18-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 19171-18-7
Chemical Structure| 19171-18-7
Structure of 19171-18-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 19171-18-7 ]

Related Doc. of [ 19171-18-7 ]

Alternatived Products of [ 19171-18-7 ]

Product Details of [ 19171-18-7 ]

CAS No. :19171-18-7 MDL No. :MFCD01748356
Formula : C13H9N3O6 Boiling Point : -
Linear Structure Formula :- InChI Key :KVRCAGKHAZRSQX-UHFFFAOYSA-N
M.W : 303.23 Pubchem ID :134775
Synonyms :

Calculated chemistry of [ 19171-18-7 ]

Physicochemical Properties

Num. heavy atoms : 22
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.23
Num. rotatable bonds : 2
Num. H-bond acceptors : 6.0
Num. H-bond donors : 1.0
Molar Refractivity : 79.77
TPSA : 129.37 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.04 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.65
Log Po/w (XLOGP3) : 0.16
Log Po/w (WLOGP) : -0.77
Log Po/w (MLOGP) : -0.02
Log Po/w (SILICOS-IT) : -1.15
Consensus Log Po/w : -0.22

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.89
Solubility : 3.9 mg/ml ; 0.0129 mol/l
Class : Very soluble
Log S (Ali) : -2.43
Solubility : 1.12 mg/ml ; 0.00368 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.42
Solubility : 1.16 mg/ml ; 0.00382 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 3.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.76

Safety of [ 19171-18-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 19171-18-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 19171-18-7 ]
  • Downstream synthetic route of [ 19171-18-7 ]

[ 19171-18-7 ] Synthesis Path-Upstream   1~21

  • 1
  • [ 641-70-3 ]
  • [ 24666-56-6 ]
  • [ 19171-18-7 ]
YieldReaction ConditionsOperation in experiment
89.7% at 25 - 118℃; for 18 h; A round bottom flask was charged with a solution of glacial acetic acid (75 ml) and α-amino glutarimide hydrochloride (8.5 g).
Sodium acetate anhydrous (4.5 g) was added lot-wise to the solution at 25° C. to 30° C. followed by addition of 3-nitro phthalic anhydride (log) at the same temperature.
The reaction mixture was stirred at 118° C. for 18 hr.
After the completion of reaction, the reaction mass was cooled to 60° C. and the solvent was distilled off under vacuum to get the residue.
To the residue obtained, water (100 ml) was added; the mixture was stirred for 1 hr at 25° C. to 30° C. and the mass filtered.
The wet cake obtained was slurried with water (100 ml*2), filtered and dried in an air tray dryer until the water content was less than 0.5percent to afford 2-(2,6-dioxopiperidin-3-yl)-4-nitroisoindoline-1,3-dione (14 g). Yield: 89.7percent, Purity: 98percent.
88.3% With sodium acetate; acetic acid In water at 116 - 118℃; for 17 h; In the 2L reaction bottle into the water 60ml, 3-nitrophthalic anhydride 65 g (336.6 mmol), 3-aminopiperidine-2,6-dione hydrochloride 53.5 g (325.0 mmol) Sodium acetate 27 g (329.3 mmol) and acetic acid (1200 ml) The reaction was stirred at 116-118 ° C for 17 h, Cooled to room temperature, filtered, Filter cake water washing, Solid at 50-60 decompression (vacuum ≥ 0.08MPa) dry 5h, That is the target product 87g, silver-gray solid, The yield was 88.3percent and the purity was 99.88percent.
Reference: [1] Patent: US2017/260157, 2017, A1, . Location in patent: Page/Page column 5
[2] Patent: CN104926786, 2017, B, . Location in patent: Paragraph 0044; 0045
[3] Synthetic Communications, 2016, vol. 46, # 16, p. 1343 - 1348
[4] Bioorganic and Medicinal Chemistry Letters, 1999, vol. 9, # 11, p. 1625 - 1630
[5] Patent: CN104402863, 2016, B, . Location in patent: Paragraph 0035
  • 2
  • [ 603-11-2 ]
  • [ 24666-56-6 ]
  • [ 19171-18-7 ]
YieldReaction ConditionsOperation in experiment
86.2% With sodium acetate; acetic acid In water at 116 - 118℃; for 16 h; 40 ml of water, 70 g (331.6 mmol) of 3-nitrophthalic acid, 3-aminopiperidine-2,6-dione hydrochloride 53.5 g (325.0 mmol) Sodium acetate 27 g (329.3 mmol) and acetic acid (1200 ml) The reaction was stirred at 116-118 ° C for 16 h, Cooled to room temperature, Filter, filter cake water washing, Solid at 50-55 decompression (vacuum ≥ 0.08MPa) dry 4h, That is the target product 85g, For silver-gray solid, The yield was 86.2percent and the purity was 99.91percent.
28.2 g With 1,1'-carbonyldiimidazole In acetonitrile at 20 - 80℃; Inert atmosphere Example 1:
Synthesis of l,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-nitro-isoindoline- dione (3-nitrophthalidomide)
To the stirred mixture of 3-nitrophthalic acid (25.0 g or 0.12 mole) in acetonitrile (175 ml) was added 1 , 1 -carbonyldiimi dazole (CD1) (42,3 g or 0.26 mole) under nitrogen atmosphere at ambient temperature. To this mixture, 3-aminopiperidine 2,6-dione hydrochloride (19.5g or 0.12 mole) was added, and the reaction mixture was heated to 75 to 80 °C until the reaction was completed as monitored by TLC. After completion of the reaction, the solvent was distilled out under reduced pressure. Water (375 ml) was added to the reaction mass, and the reaction mass was slowly cooled at 0 to 5 °C while stirring. The isolated solid was filtered, washed with water, then by methanol, and suck dried. Finally the isolated solid was dried at 55 to 60 °C under vacuum until constant weight to obtain 3-nitrophthalidomide. Yield: 28.2 g, 78.5percent (molar) (HPLC purity -99.5percent)
Reference: [1] Patent: CN104926786, 2017, B, . Location in patent: Paragraph 0039; 0040
[2] Patent: WO2015/75694, 2015, A1, . Location in patent: Page/Page column 2; 4; 8
  • 3
  • [ 641-70-3 ]
  • [ 19171-18-7 ]
YieldReaction ConditionsOperation in experiment
84.2%
Stage #1: With triethylamine In toluene for 8 h; Reflux
Stage #2: With 1,1'-carbonyldiimidazole In toluene at 20 - 25℃; for 2 h;
In a mixer equipped with a mechanical stirrer, (0.124 mol, 1.069) of 3-nitrophthalic anhydride, 21.5 g (0.130 mol, 1.05 eq) of 3-aminopiperidine-2,6-diamine were added to a 500 mL four-necked flask equipped with a thermometer and a water separator. (0.148 mol, 1.2 eq) of triethylamine was added and the mixture was gradually warmed up to reflux to separate water. The reaction solution was changed to a purple suspension, and the mixture was refluxed for a further period of time Water for 8 hours, HPLC control: to be 3-nitrophthalic anhydride content of raw materials <0.5percent, the reaction temperature dropped to 20 ~ 25 ° C, the reactor by adding 6.0g N, N'-carbonyl (0.037mol, 0.3eq), slowly heated to reflux stirring 2 hours, HPLC control: to be intermediate content <0.5percent, the reaction solution to 20 ~ 25 ° C when the filter, the mother liquor retained to apply, filter cake Into another 250mL reaction bottle, add 60mL of methanol and 60mL of water mixture beating for 2 hours, filtration, the light purple solid wet weight 48.2g, can be directly used for the next reaction, dry goods calculated 3-nitro The yield was 84.2percent. Melting point: 278.0 to 282.0 ° C (DSC). The purity of the product was determined by HPLC. The purity of the product was measured by HPLC. Was 98.35percent, with HPLC using a Waters XTerra MS Cl8 column (4.6 * 150 mm, particle size = 3.5 micron, UV wavelength = 210nm, intermediate retention time = 7.0 min, product retention time = 12.1 min) and Gradient elution with 0.1percent (v / v) aqueous phosphoric acid and acetonitrile as mobile phase at a flow rate of 1.0 ml / min
141.60 g
Stage #1: at 25 - 35℃;
Stage #2: at 25 - 35℃;
Stage #3: at 25℃; Reflux
In to a well cleaned and oven dried 2.OL 4neck RB flask, 97.96g of 3-aminoglutarimide hydrochloride and 500.Oml of Acetic acid were charged. Reaction mass was stirred for 5-10mm at 25-35°C. 100.Og of 4-nitrophthalic anhydride was charged in to the reaction mass.Reaction mass was stirred for 5-10mm at 25-35°C. 1 14.8g of Triethyl amine was added to the reaction mass, at 25- 35°C, in about 30-45mm. Reaction mass was maintained at 25- 35°C, for 20- 30mm. Reaction mass temperature was raised to reflux, maintained for 3.0-3.5 hours. After completion reaction, reaction mass was cooled to 25-35°C, maintained for 45-60mm. Solid reaction mass was filtered under vacuum, washing was given with 200.Oml of DM water, suck dried for 20-30mm. Wet compound is charged in to the 500.Oml 4neck RB flask, 460.Oml of DM water was charged in to the flask. Reaction mass was stirred for 20-30mm, at 25-35°C.Solid reaction mass was filtered under vacuum, washing was given with 200.Oml of DM Water, suck dried for 45-60min.Wet compound was dried in a vacuum oven, at 60-65°C, for 3-4hours, under vacuum. (68OmmJHg).Yield: 141.6.Og
Reference: [1] Patent: CN103804350, 2016, B, . Location in patent: Paragraph 0030
[2] Patent: WO2017/221261, 2017, A1, . Location in patent: Page/Page column 5
  • 4
  • [ 603-62-3 ]
  • [ 24666-56-6 ]
  • [ 19171-18-7 ]
YieldReaction ConditionsOperation in experiment
88% With 1,1'-carbonyldiimidazole In acetonitrile at 80 - 82℃; 4-Nitro-lH-isoindole-l, 3(2H)-dione (117.3 g; Formula IV) followed by 1,1- carbonyldiimidazole (138.1 g) were added to a slurry of 3-aminopiperidine-2,6-dione hydrochloride (100 g, Formula III; obtained in Example 1) in acetonitrile (800 mL) to obtain a reaction mixture. The reaction mixture was heated to reflux at 80°C to 82°C and then stirred for 2 hours. 1,1-Carbonyldiimidazole (19.8 g) was further added to the reaction mixture twice over an interval of one hour. The reaction mixture was cooled to 25 °C to 30°C and then stirred for 30 minutes. The product obtained was filtered and the wet solid obtained was dried at 50°C to 55°C under reduced pressure to obtain the title compound. (0076) Yield: 162 g (88percent)
Reference: [1] Patent: WO2018/154516, 2018, A1, . Location in patent: Page/Page column 8
  • 5
  • [ 6383-80-8 ]
  • [ 19171-18-7 ]
YieldReaction ConditionsOperation in experiment
71% With ammonia In dimethyl sulfoxide at 200℃; for 1 h; Industrial scale N,N-Dimethylformamide (50kg) was drawn into the reactor.Glutamic acid (32 kg), 3-nitrophthalic anhydride (40 kg) was added under stirring, followed by heating and reaction at 95-100°C for 3 hours.Then, N,N-dimethylformamide was evaporated under reduced pressure, acetic anhydride (50 kg) was added with cooling, and the mixture was heated to 100-110° C. for 1 hour. The excess anhydride was distilled off under reduced pressure. DMSO (400 L) was added and the reaction was heated to 200°C,Ammonia was slowly introduced under stirring. After the reaction was complete, methanol (800 L) was added to cool to room temperature, the crystals were centrifuged, and dried to obtain 3-nitrophoramide (62.76 kg) in a yield of 71percent. Purity 99.99percent.3-nitrophoramide (30kg) was dissolved in 1,4-dioxane\methanol=300L\300L, 10percent palladium on carbon, 35°C, 0.4M,Hydrogenation to the completion of the reaction, pressure filter, concentrated under reduced pressure, add DMF (300L) dissolved, isopropyl ether (600L) crystallization, centrifugedThe yellow product was recrystallized from ethanol to obtain high-purity pomametide. HPLC: 99.84percent.
Reference: [1] Patent: CN107365295, 2017, A, . Location in patent: Paragraph 0014; 0015
  • 6
  • [ 641-70-3 ]
  • [ 19171-18-7 ]
YieldReaction ConditionsOperation in experiment
75% for 4.5 h; Reflux; Inert atmosphere 1.
2-(2,6-Dioxopiperidine-3-yl)-4-nitrophthalimide (7)
A mixture of 3-nitrophthalic anhydride (6) (1.5 g, 7.8 mmol) and (2,6-dioxopiperidine-3-yl)amine trifluoroacetate (1.9 g, 7.8 mmol) in acetic acid (60.0 mL) was refluxed for 4.5 h under a nitrogen atmosphere.
After removing solvent, the residues were recrystallized with ethyl acetate to afford product (7) (1.8 g, 75.0percent) as a purplish solid.
66.4% for 6 h; Reflux 4-Nitro-2-benzofuran -1,3-dione (7) (280.0 g, 1.4 mmol) andAcONa (177.0 mg, 2.1 mmol) were added to a solution of 3-aminopiperidine-2,6-dione trifluoroacetate (8) (350.0 g, 1.4 mmol) in aceticacid (30 mL) and the reaction mixture was stirred at refluxing for 6 h.After the mixture was cooled to room temperature, gray solid precipitated,which was filtered out and washed with water to give compound9 (Yield: 290.0 mg, 66.4percent). ESI-MS: calcd m/z=303.05, found[M+H]+=304.05, [M+Na]+=326.03 and [M+K]+=342.00.
Reference: [1] Patent: US2013/143922, 2013, A1, . Location in patent: Paragraph 0089
[2] Bioorganic Chemistry, 2018, vol. 81, p. 536 - 544
[3] Patent: WO2017/59062, 2017, A1, . Location in patent: Sheet 1
  • 7
  • [ 641-70-3 ]
  • [ 118061-00-0 ]
  • [ 19171-18-7 ]
Reference: [1] Patent: US9365640, 2016, B2, . Location in patent: Page/Page column 66
  • 8
  • [ 641-70-3 ]
  • [ 31140-42-8 ]
  • [ 19171-18-7 ]
Reference: [1] ChemMedChem, 2018, vol. 13, # 15, p. 1508 - 1512
[2] ACS Chemical Biology, 2018, vol. 13, # 9, p. 2771 - 2782
  • 9
  • [ 2650-64-8 ]
  • [ 19171-18-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 1999, vol. 9, # 11, p. 1625 - 1630
[2] Patent: US9365640, 2016, B2,
  • 10
  • [ 24666-55-5 ]
  • [ 19171-18-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 1999, vol. 9, # 11, p. 1625 - 1630
  • 11
  • [ 603-11-2 ]
  • [ 19171-18-7 ]
Reference: [1] Synthetic Communications, 2016, vol. 46, # 16, p. 1343 - 1348
[2] Patent: CN104402863, 2016, B,
[3] Patent: WO2017/221261, 2017, A1,
  • 12
  • [ 85535-45-1 ]
  • [ 19171-18-7 ]
Reference: [1] Patent: WO2017/59062, 2017, A1,
[2] ChemMedChem, 2018, vol. 13, # 15, p. 1508 - 1512
  • 13
  • [ 22785-43-9 ]
  • [ 19171-18-7 ]
Reference: [1] Patent: US9365640, 2016, B2,
  • 14
  • [ 31140-42-8 ]
  • [ 19171-18-7 ]
Reference: [1] Patent: WO2017/59062, 2017, A1,
  • 15
  • [ 617-65-2 ]
  • [ 19171-18-7 ]
Reference: [1] Patent: CN107365295, 2017, A,
  • 16
  • [ 641-70-3 ]
  • [ 19171-18-7 ]
Reference: [1] Patent: CN107365295, 2017, A,
  • 17
  • [ 18636-08-3 ]
  • [ 19171-18-7 ]
Reference: [1] Patent: CN107365295, 2017, A,
  • 18
  • [ 496-12-8 ]
  • [ 19171-18-7 ]
  • [ 827026-45-9 ]
  • [ 1063995-54-9 ]
Reference: [1] Patent: CN107488167, 2017, A,
  • 19
  • [ 641-70-3 ]
  • [ 2353-44-8 ]
  • [ 19171-18-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 3, p. 878 - 881
  • 20
  • [ 19171-18-7 ]
  • [ 19171-19-8 ]
YieldReaction ConditionsOperation in experiment
93.3% With palladium 10% on activated carbon; hydrogen In water; N,N-dimethyl-formamide at 35℃; for 3 h; To the reaction flask was added 33-nitro-N-(2,6-dioxo-3-piperidinyl)phthalimide (II) (100.0g, 0.33mol), 10percent palladium on carbon 12.0g, DMF 1000ml, 70ml water, vacuum, hydrogen gas was introduced (replacement three times), the reaction normal pressure at 35 °C for 3h, TLC monitored the reaction was completed, the palladium carbon was filtered off, the DMF solution was slowly added to 5-fold amount of water, stirring about 30min, then the solid was filtered, the filter cake was washed with an appropriate amount of water (2L * 3 times, 30min/time), the filter cake was washed with 200ml of ethanol, and the solid was transferred to a one-neck 3L flask was charged with 2L of ethyl acetate at 73 °C stirred 0.5h, filtered hot and the solid was dried at 45 °C to constant weight to give a yellow solid powder 84.1g, a yield of 93.3percent. percent HPLC purity 99.9,
91% With palladium on activated charcoal; hydrogen In 1-methyl-pyrrolidin-2-one at 45℃; (1) 100g 3-nitro-N-(2,6-dioxo-3-piperidinyl)phthalimide, 10g of the palladium-carbon and 1000 ml N-methylpyrrolidone were added into a 2000 ml hydrogenation reactor. Vacuum. After nitrogen replacement 3 times, place hydrogen gas, regulating the reactor pressure to 0.3 MPa, control temperature at 45 °C. After the reaction is complete, filtering, the filtrate by adding 30g charcoal, heating up to 70 °C, stirring 3 hours, filtered;
(2) to the step (1) and the finally obtained by adding sodium carbonate aqueous solution in the filtrate (2g sodium carbonate dissolved in 10 ml purified water to prepare water), stirring at room temperature for 0.5 hours, then slowly dropping 2000 ml purified water, lowering the temperature to 10 °C crystallization, filtered, the filter cake is added to 500 ml of purified water, stirring at room temperature for 0.5 hours, filtered, washed with water purification cake, solid 60 °C obtained by vacuum drying the yellow powdery solid 82g, yield 91percent. HPLC detection the purity is 99.88percent.
80% With palladium 10% on activated carbon; hydrogen In N,N-dimethyl acetamide at 30℃; for 7 h; Add 5 g of 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-5-nitroisoindoline and 0.4 g of 10percent palladium carbon to 50 mL of N,N - in dimethylacetamide,The hydrogenation reaction is then carried out at 0.45 MPa at 30 ° C.Lasted 7 hours,Filter to remove the catalyst,The filtrate was concentrated under vacuum.The concentrate was beaten with water overnight.Obtained 3.6 g of a yellow solid.That is, the target compound.Yield 80percent,The purity measured by HPLC was 99.4percent.
79.5% With palladium 10% on activated carbon; hydrogen In 1,4-dioxane at 60 - 65℃; for 6 h; In a mixer equipped with a mechanical stirrer, A thermometer and a ventilator was charged with 31.7 g (wet product 48.2 g, 0.105 mol, 1.0 eq) 3-nitro-N-(2,6-dioxo-3-piperidinyl) phthalimide,1.6 g of 10percent palladium on carbon and 395 mL of solvent 1,4-dioxane,Stirring to form a suspension of hydrogen gas bubbling, bubbling speed 1 times / second, the temperature of the reaction solution to 60 ~ 65 ° C, continue stirring for 6 hours, HPLC control: to be raw materials and intermediate content <0.5percent The filtrate was concentrated under reduced pressure and 158 mL of ethyl acetate was added to the residue. The mixture was stirred for 2 hours and then filtered. The cake was transferred to another 500 mL reaction flask and 158 mL of N , N-dimethylformamide, heating to 55 ~ 60 ° C stirring, 55 ~ 60 ° C drop 316 mL of purified water, heating to 70 ~ 75 ° C for 2 hours, cooling to a temperature of 30 ~ 35 ° C, filter, wet goods to vacuum drying oven 50 ~ 55 ° C drying, 3-amino-N - (2,6-dioxo-3-piperidyl) phthalimide 22.7 G, pale yellow powdery solid, yield 79.5percent, m.p. 315.0~318.0 ° C (DSC). The purity of the product was 99.73percent by HPLC, with a single impurity <0.10percent, of which 13percent UV retention time = 11.5 min.), And using 0.1percent (v (v / v)) as the mobile phase, / Ν) phosphoric acid aqueous solution and acetonitrile as a mobile phase at a flow rate of 1.0 ml / min.
77.7% With hydrogen In 1,4-dioxane; water at 20 - 25℃; for 60 h; A round bottomed flask was charged with 1,4-dioxane (600 ml) and 2-(2,6-dioxopiperidin-3-yl)-4-nitroisoindoline-1,3-dione (10 g).
The mixture was stirred at 25° C. to 30° C. for 15 minutes, the temperature was raised up to 80° C. and the reaction mass stirred to obtain a clear solution.
To the clear solution activated charcoal (5 g) was added at 80° C., the mixture stirred and the solution cooled to 25° C. to 30° C.
The reaction mass was further stirred for 20 minutes at this temperature and filtered.
To the obtained solution 1,4-dioxane (300 ml), water (180 ml) and Raney nickel (0.5 g) were added.
The reaction mixture was stirred at 20° C. to 25° C. under 70 psi hydrogen pressure for 12 hrs.
Raney nickel (0.5 g) was added to the reaction mixture at 20° C. to 25° C. and the reaction continued at the same temperature and pressure for 12 hrs.
Another portion of Raney nickel (0.5 g) was added to the reaction mixture and the reaction continued at the same temperature and pressure for 12 hr.
Another portion of Raney nickel (0.5 g) was added to the mixture and the reaction continued at the same temperature and pressure for 12 hr.
Another portion of Raney nickel (0.5 g) was added to the reaction mixture and the reaction continued at the same temperature and pressure for 12 hr.
The reaction mixture was then filtered through a celite bed and the solvent was distilled off from the reaction mixture under vacuum at 50° C. to obtain a solid.
To the solid obtained 1,4-dioxane (50 ml) and ethyl acetate (5 ml) were added and the mixture was heated to 80° C. with stirring for 1 hr.
The reaction mass was filtered at 80° C. and the obtained cake washed with 1,4-dioxane (10 ml) at 80° C.
To the wet cake ethyl acetate (100 ml) was added and the mixture was refluxed with stirring for 1 hr.
Then the reaction mass was cooled to 25° C. to 30° C., the solid filtered, washed with ethyl acetate (20 ml) and dried under vacuum to get 4-amino-2-(2,6-dioxopiperidin-3-yl) isoindoline-1,3-dione (7 g). Yield: 77.7percent Purity: 99percent.
46% With triethylsilane; potassium fluoride; palladium diacetate In tetrahydrofuran; water at 20℃; for 1 h; A solution of 2-(2,6-dioxopiperidin-3 -yl)-4-nitroisoindoline- 1,3 -dione (173 mg, 0.854 mmol), Pd(OAc)2 (12.8 mg, 0.0854 mmol, 10 molpercent) and potassium fluoride (66 mg, 1.71 mmol, 2 equiv) in THF:water (8:1) (5.7 mL, 0.1 M) was stirred at room temperature. Triethylsilane (3651iL, 3.41 mmol, 4 equiv) was added slowly, and the resulting black solution was stirred at room temperature for 1 hour. The reaction mixture was filtered through a pad of celite, which was washed excessively with ethyl acetate. The filtrate was concentrated in vacuo and the residue was purified by flash column chromatography on silica gel (CH2C12:MeOH (7:1)) to afford the titlecompound as a yellow powder (72 mg, 46percent). 1H NMR (500 IVIHz, DMSO-d6) 11.08 (s, 1H),7.47 (dd, J 8.5, 7.0 Hz, 1H), 7.06 — 6.95 (m, 1H), 6.59 —6.44 (m, 1H), 5.04 (dd, J= 12.7, 5.4Hz, 1H), 2.93 — 2.82 (m, 1H), 2.64 — 2.45 (m, 2H), 2.05 — 1.98 (m, 1H); MS (ESI) calcd forC13H11N304 [M+H] 274.08, found 274.23.
46% With triethylsilane; potassium fluoride; palladium diacetate In tetrahydrofuran; water at 20℃; for 1 h; A solution of 2-(2,6-dioxopiperidin-3-yl)-4-nitroisoindoline-1,3-dione (173 mg, 0.854 mmol), Pd(OAc)2 (12.8 mg, 0.0854 mmol, 10 molpercent) and potassium fluoride (66 mg, 1.71 mmol, 2 equiv) in THF:water (8:1) (5.7 mL, 0.1 M) was stirred at room temperature. Triethylsilane (365 μL, 3.41 mmol, 4 equiv) was added slowly, and the resulting black solution was stirred at room temperature for 1 hour. The reaction mixture was filtered through a pad of celite, which was washed excessively with ethyl acetate. The filtrate was concentrated in vacuo and the residue was purified by flash column chromatography on silica gel (CH2Cl2:MeOH (7:1)) to afford the title compound as a yellow powder (72 mg, 46percent). 1H NMR (500 MHz, DMSO-d6) δ 11.08 (s, 1H), 7.47 (dd, J = 8.5, 7.0 Hz, 1H), 7.06- 6.95 (m, 1H), 6.59- 6.44 (m, 1H), 5.04 (dd, J = 12.7, 5.4 Hz, 1H), 2.93- 2.82 (m, 1H), 2.64- 2.45 (m, 2H), 2.05- 1.98 (m, 1H); MS (ESI) calcd for C13H11N3O4 [M+H]+ 274.08, found 274.23.
44.4% With iron; ammonium chloride In ethanol; water at 20℃; 9 (410.0 mg, 1.4 mmol), NH4Cl(360.0 mg, 7.0 mmol) and iron powders (380.0 mg, 7.0 mmol) weremixed in a EtOH/H2O (v:v=7:3) solution (40 mL). The resultingmixture was kept stirring at room temperature overnight. Then saturatedNaHCO3 solution was added to the reaction mixture which wasthen extracted with ethyl acetate. The organic layer was dried oversodium sulfate, filtered and concentrated under reduced pressure togive compound 10 as a yellow powder (Yield: 163.0 mg, 44.4percent). ESIMS:calcd m/z=273.07, found [M+H]+=274.07, [M+Na]+=296.05 and [2 M+Na]+=569.12 . 1H NMR (ppm,400 MHz, DMSO‑d6): δ 11.11 (s, 1H), δ 7.47 (q, J=6.0 Hz, 1H), δ 7.01(q, J=6.0 Hz, 2H), δ 6.54 (s, 2H), δ 5.05 (q, J=10.0 Hz, 1H), δ 2.89(m, 1H), δ 2.57 (m, 2H), δ 2.02 (m, 1H). 13C NMR (ppm, 100 MHz,DMSO‑d6): δ 173.32, 170.63, 169.04, 167.85, 147.19, 135.94, 132.47,122.18, 111.46, 108.97, 48.95, 31.46, 22.62
136 g With palladium 10% on activated carbon; hydrogen In N,N-dimethyl-formamide at 20℃; for 3 h; Dimethylformamide (1500 ml) was added to 3-(4-nitro-l-oxoisoindolin-2- yl)piperidine-2,6-dione (150 gm) and then stirred for 30 minutes at room temperature to obtain a clear solution. To the solution was added 10percent palladium carbon and then applied 4 Kg of hydrogen pressure at room temperature. The reaction mass was stirred for 3 hours at room temperature and temperature of the reaction mass was raised to 60 to 65°C. The reaction mass was filtered through hi-flow bed and then concentrated to obtain a residual solid. To the residual solid was added ethyl acetate (600 ml) and then heated to reflux. The reaction mass was maintained for 30 minutes at reflux and then cooled to room temperature. The contents were stirred for 1 hour at room temperature and filtered. The solid obtained was then dried to obtain 136 gm of pomalidomide. Chromatographic purity: 97.5percent.
8.2 g With palladium 10% on activated carbon; hydrogen In N,N-dimethyl-formamideInert atmosphere Example 3:
Synthesis of 4-amino-2-(2,6-dioxopiperidin-3-yl)-isoindoIine-l,3-(lione (Pomalidomide)
Catalyst palladium (10percent) on carbon (0.5 g. or 5percent w/w of substrate ) was added to a stirred solution of 3-nitrophthalidomide (10 g or 0.033 mole) (Example 1 ) in N,N- dimethyl formamide (100 ml) maintained under nitrogen. Hydrogen gas was bubbled through the reaction mixture at atmospheric pressure. After completion of hydrogenation reaction, as monitored by TLC, hydrogen bubbling was stopped and the catalyst was separated by filtration of the reaction mixture on celite bed. The filtrate was distilled at 60 to 65 °C under reduced pressure until half of the solvent was removed. The solution was then cooled at ambient temperature and methanol (50 ml) was added while stirring. The solid obtained was filtered, washed with methanol (50 ml), and suck dried to obtain pomalidomide 8.2 g (90percent molar yield) having HPLC purity > 99.0percent.
216.7 g at 105℃; for 5 h; Add 240g iron powder in batches,Control reaction temperature does not exceed 105 stirring reaction 5 hours,Cool to room temperature.filter,Filter cake washed with water,And then washed with sodium bicarbonate solution,After filtration, the crude product.The crude product was dissolved in 2400 ml of dimethylsulfoxide,filter.Add water to the filtrate,The precipitated solid was collected by filtration,Dry at 60 for 4 h.216.7 g of a yellow solid, yield: 79.3percent, purity: 99.93percent.
3.7 g With palladium 10% on activated carbon; hydrogen In N,N-dimethyl acetamide at 30℃; for 6 h; 5 g of 1,3-dioxo-2- (2,6-dioxopiperidin-3-yl) -5-nitroisoindoline 10percent palladium carbon 0.4g mixed into 70 mL of N, N-dimethylacetamide, The hydrogenation reaction was then carried out at 0.4 MPa, The reaction temperature was 30 ° C, Lasted 6 hours, Filter out the catalyst, The filtrate was concentrated in vacuo, The residue was beaten overnight at 40 ° C with 40 mL of water, Get 3.7g Yellow-green solid of thalidomide crude. HPLC with a purity of 99.0percent.
85 g With palladium 10% on activated carbon; hydrogen In N,N-dimethyl-formamide at 15 - 20℃; In to a well cleaned and oven dried 3 .OL 4neck RB flask, to a mechanical stirrer and equipped with thermometer socket, condenser (fitted with gas outlet dipped in to the water), gas-inlet(connected with single trap filled with dimethylfonnamide up to bubbling nossile), 100.Og of 2-(2, 6-dioxo-3 -piperidyl)-4-nitro-isoindoline- 1, 3 -dione, 1 550.Oml of dimethylformamide were charged. Reaction mass was stirred for 10-15mm at 25-35°C, clear solution was observed. 13.0g of 10percent Pd/c was charged in to the reaction mass, in presence of N2 gas atmosphere, washing was given with 50.0 ml of dimethylfonnamide. H2 gas was bubbled in to the reaction mass, for 6.5-7.0 hours, at 15-20°C. After completion of reaction, eaction mass is filtered under vacuum, through hyflow, in presence of N2 gas atmosphere, washing is given with 300.Oml of dimethylfonnamide. Filtrate is transferred in to a 5.OL 4 neck RB flask. Slowly added DM Water (1900.0m1) to the reaction mass over a period of 45-60mm at 15-20°C, Stirred the reaction mass at 15-20°C for 60-90mm. Solid reaction mass was filtered under vacuum, washing was given with 200.Oml DM Water, suck dried for 45-60mm. wet compound is dried in a vacuum oven at 60-650C, under vacuum (600-65OmmJHg) for 2-3hours and characterized as form A of pomalidomide.Yield: 85.0 g

Reference: [1] Patent: CN105348257, 2016, A, . Location in patent: Paragraph 0051; 0052; 0053
[2] Patent: CN106565668, 2017, A, . Location in patent: Paragraph 0053; 0054; 0055; 0056-0061
[3] Patent: CN104557858, 2018, B, . Location in patent: Paragraph 0032; 0033; 0036; 0038; 0040; 0042; 0044; 0046
[4] Patent: CN103804350, 2016, B, . Location in patent: Paragraph 0029; 0031
[5] Patent: US2017/260157, 2017, A1, . Location in patent: Paragraph 0057; 0058; 0059; 0060; 0061; 0062; 0063
[6] Synthetic Communications, 2016, vol. 46, # 16, p. 1343 - 1348
[7] Patent: WO2018/148440, 2018, A1, . Location in patent: Page/Page column 297; 300; 301
[8] Patent: WO2018/148443, 2018, A1, . Location in patent: Page/Page column 281-282
[9] Bioorganic Chemistry, 2018, vol. 81, p. 536 - 544
[10] Bioorganic and Medicinal Chemistry Letters, 1999, vol. 9, # 11, p. 1625 - 1630
[11] Chemical and Pharmaceutical Bulletin, 2006, vol. 54, # 6, p. 855 - 860
[12] Patent: US6335/349, 2002, B1, . Location in patent: Example 1
[13] Patent: US6335349, 2002, B1, . Location in patent: Example 1
[14] Patent: US2013/143922, 2013, A1, . Location in patent: Paragraph 0091
[15] Patent: WO2014/170909, 2014, A2, . Location in patent: Page/Page column 5
[16] Patent: WO2015/75694, 2015, A1, . Location in patent: Page/Page column 2; 4; 9
[17] Patent: CN104402863, 2016, B, . Location in patent: Paragraph 0035
[18] Patent: CN107188884, 2017, A, . Location in patent: Paragraph 0019; 0033; 0034; 0036
[19] Patent: CN107365295, 2017, A, . Location in patent: Paragraph 0014; 0015
[20] Patent: WO2017/221261, 2017, A1, . Location in patent: Page/Page column 5; 6
[21] Patent: WO2018/154516, 2018, A1, . Location in patent: Page/Page column 8
[22] ACS Chemical Biology, 2018, vol. 13, # 9, p. 2771 - 2782
  • 21
  • [ 19171-18-7 ]
  • [ 67-64-1 ]
  • [ 19171-19-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 3, p. 878 - 881
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 19171-18-7 ]

Pomalidomide Related Intermediates

Chemical Structure| 6946-22-1

[ 6946-22-1 ]

3-Aminophthalic acid hydrochloride

Chemical Structure| 24666-56-6

[ 24666-56-6 ]

3-Aminopiperidine-2,6-dione hydrochloride

Chemical Structure| 56-85-9

[ 56-85-9 ]

(S)-2,5-Diamino-5-oxopentanoic acid

Chemical Structure| 617-65-2

[ 617-65-2 ]

DL-Glutamic acid

Chemical Structure| 641-70-3

[ 641-70-3 ]

3-Nitrophthalic anhydride

Related Functional Groups of
[ 19171-18-7 ]

Amides

Chemical Structure| 827026-45-9

[ 827026-45-9 ]

3-(4-Nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Similarity: 0.88

Chemical Structure| 603-62-3

[ 603-62-3 ]

3-Nitrophthalimide

Similarity: 0.83

Chemical Structure| 41663-84-7

[ 41663-84-7 ]

2-Methyl-5-nitroisoindoline-1,3-dione

Similarity: 0.81

Chemical Structure| 21091-98-5

[ 21091-98-5 ]

(4-Methylpiperazin-1-yl)(4-nitrophenyl)methanone

Similarity: 0.81

Chemical Structure| 366452-97-3

[ 366452-97-3 ]

4-Nitroisoindolin-1-one

Similarity: 0.81

Nitroes

Chemical Structure| 827026-45-9

[ 827026-45-9 ]

3-(4-Nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Similarity: 0.88

Chemical Structure| 603-62-3

[ 603-62-3 ]

3-Nitrophthalimide

Similarity: 0.83

Chemical Structure| 41663-84-7

[ 41663-84-7 ]

2-Methyl-5-nitroisoindoline-1,3-dione

Similarity: 0.81

Chemical Structure| 21091-98-5

[ 21091-98-5 ]

(4-Methylpiperazin-1-yl)(4-nitrophenyl)methanone

Similarity: 0.81

Chemical Structure| 366452-97-3

[ 366452-97-3 ]

4-Nitroisoindolin-1-one

Similarity: 0.81

Related Parent Nucleus of
[ 19171-18-7 ]

Indolines

Chemical Structure| 827026-45-9

[ 827026-45-9 ]

3-(4-Nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Similarity: 0.88

Chemical Structure| 603-62-3

[ 603-62-3 ]

3-Nitrophthalimide

Similarity: 0.83

Chemical Structure| 41663-84-7

[ 41663-84-7 ]

2-Methyl-5-nitroisoindoline-1,3-dione

Similarity: 0.81

Chemical Structure| 366452-97-3

[ 366452-97-3 ]

4-Nitroisoindolin-1-one

Similarity: 0.81

Chemical Structure| 191732-76-0

[ 191732-76-0 ]

5-Amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione

Similarity: 0.79

Piperidines

Chemical Structure| 827026-45-9

[ 827026-45-9 ]

3-(4-Nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Similarity: 0.88

Chemical Structure| 191732-76-0

[ 191732-76-0 ]

5-Amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione

Similarity: 0.79

Chemical Structure| 1800044-76-1

[ 1800044-76-1 ]

(Z)-N-(1-Chloro-1-(2-nitrophenyl)-3-oxo-3-(piperidin-1-yl)prop-1-en-2-yl)benzamide

Similarity: 0.71

Chemical Structure| 1381795-31-8

[ 1381795-31-8 ]

(R)-2-(Piperidin-3-yl)isoindoline-1,3-dione hydrochloride

Similarity: 0.68

Chemical Structure| 96-88-8

[ 96-88-8 ]

N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide

Similarity: 0.68